Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 07:30 ET | Source: Kailera Therapeutics, Inc.

Kailera Therapeutics Appoints Frank Clyburn to Board of Directors

Kailera Therapeutics appoints 30-year biopharma industry veteran Frank Clyburn, Jr to its Board of Directors
October 28, 2025 10:30 ET | Source: Heald

Former Amazon Care Executive Dr. Sunita Mishra Joins Heald’s Advisory Board to Accelerate Expansion Across Employers and Provider Networks

ALPHARETTA, Ga., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Heald, the human-led, tech-enabled platform redefining Diabetes care, proudly announces that Dr. Sunita Mishra, former Chief Medical Officer of...
October 27, 2025 08:00 ET | Source: Biomea Fusion, Inc.

Biomea Fusion Announces First Patient Dosed in Phase I Study of BMF-650 a Next-Generation Oral GLP-1 Receptor Agonist

SAN CARLOS, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea,” “Biomea Fusion” or the “Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today...
October 21, 2025 07:00 ET | Source: Kailera Therapeutics, Inc.

Hengrui Pharma and Kailera Therapeutics Announce Phase 3 HRS9531 Obesity Data Presentation at ObesityWeek® 2025

Hengrui Pharma and Kailera today announced an oral presentation of HRS9531 Phase 3 data at ObesityWeek® 2025, the annual meeting of the Obesity Society.
October 20, 2025 06:30 ET | Source: WW International Inc.

WeightWatchers Collaborates With Amazon Pharmacy to Increase Medication Delivery Speed, Convenience and Savings For Members

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, today announced a...
October 17, 2025 09:10 ET | Source: WW International Inc.

WeightWatchers Launches RxFlexFund™, a New Employer Model for Expanding GLP-1 Coverage

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, today announced the launch...
October 15, 2025 11:05 ET | Source: WW International Inc.

WeightWatchers for Business Annual Report Shows Breakthrough Weight Loss Results and Health Outcomes

Members See 46% Improvement in Work-Related Quality of Life and 53% Improvement in Overall Quality of Life WeightWatchers Members Lost 21% of Their Body Weight, Outperforming Results by Other...
October 14, 2025 06:30 ET | Source: Kailera Therapeutics, Inc.

Kailera Therapeutics Announces $600 Million Series B Financing to Further Advance Pipeline of Next-Generation Therapies for the Treatment of Obesity

Kailera Therapeutics announced a $600M Series B financing led by new investor Bain Capital Private Equity to support its late-stage obesity portfolio.
October 07, 2025 09:00 ET | Source: Neurogastrx

Neurogastrx to Present Proof-of-Concept Clinical Data on Oral Candidate NG101 to Reduce Nausea & Vomiting Associated with GLP-1 Agonists at ObesityWeek®

Neurogastrx to Present Proof-of-Concept Clinical Data on Oral Candidate NG101 to Reduce Nausea & Vomiting Associated with GLP-1 Agonists at ObesityWeek®
October 07, 2025 05:00 ET | Source: Resalis Therapeutics SRL

Resalis Therapeutics Reports Durable, Fat-Selective Weight Loss with RES-010 in Non-Human Primates at Multiple Scientific and Industry Meetings

Torino, Italy, October 7 – Resalis Therapeutics, a biotechnology company pioneering microRNA-targeted therapies, presented new preclinical results on its lead candidate RES-010, a first-in-class...